AN2 Therapeutics, Inc. — SCHEDULE 13D/A Filings
2 SCHEDULE 13D/A filings on record
This page lists all SCHEDULE 13D/A filings submitted to the SEC by AN2 Therapeutics, Inc. (ANTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. AN2 Therapeutics, Inc. has filed 2 SCHEDULE 13D/A documents with the SEC since 2021. To view all SEC filings by AN2 Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001373604-25-000092 | Jun 18, 2025 | — |
| SCHEDULE 13D/A | — | 0001373604-25-000086 | May 30, 2025 | — |